NYSE - Delayed Quote • USD
Koninklijke Philips N.V. (PHG)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 7:13 PM EDT
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 1 | 1 | 8 | 8 |
Avg. Estimate | 0.28 | 0.33 | 1.44 | 1.7 |
Low Estimate | 0.28 | 0.33 | 0.88 | 1.21 |
High Estimate | 0.28 | 0.33 | 1.61 | 1.95 |
Year Ago EPS | -- | 0.3 | 1.33 | 1.44 |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 1 | 1 | 9 | 9 |
Avg. Estimate | 4.47B | 4.82B | 20.18B | 21.17B |
Low Estimate | 4.47B | 4.82B | 19.88B | 20.76B |
High Estimate | 4.47B | 4.82B | 20.93B | 22B |
Year Ago Sales | -- | -- | 19.38B | 20.18B |
Sales Growth (year/est) | -- | -- | 4.10% | 4.90% |
Earnings History
CURRENCY IN USD | 6/30/2023 | 9/30/2023 | 12/31/2023 | |
---|---|---|---|---|
EPS Est. | -- | 0.31 | 0.35 | 0.6 |
EPS Actual | -- | 0.3 | 0.36 | 0.44 |
Difference | -- | -0.01 | 0.01 | -0.16 |
Surprise % | -- | -3.20% | 2.90% | -26.70% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | 0.28 | 0.33 | 1.44 | 1.7 |
7 Days Ago | 0.28 | 0.33 | 1.43 | 1.68 |
30 Days Ago | 0.3 | 0.34 | 1.45 | 1.71 |
60 Days Ago | 0.3 | 0.34 | 1.5 | 1.77 |
90 Days Ago | 0.34 | 0.37 | 1.61 | 1.96 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
CURRENCY IN USD | PHG | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | -- | -- | -- | 5.40% |
Next Qtr. | 10.00% | -- | -- | 10.90% |
Current Year | 8.30% | -- | -- | 4.50% |
Next Year | 18.10% | -- | -- | 13.10% |
Next 5 Years (per annum) | 16.69% | -- | -- | 10.94% |
Past 5 Years (per annum) | 11.31% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
Downgrade | Societe Generale: Buy to Hold | 7/25/2022 |
Downgrade | Jefferies: Buy to Hold | 1/20/2022 |
Upgrade | HSBC: Hold to Buy | 1/14/2022 |
Downgrade | Citigroup: Buy to Neutral | 1/12/2022 |
Downgrade | Deutsche Bank: Buy to Hold | 7/8/2021 |
Upgrade | JP Morgan: Neutral to Overweight | 3/18/2021 |
Related Tickers
SNN Smith & Nephew plc
24.45
+2.39%
PODD Insulet Corporation
166.19
+1.23%
EW Edwards Lifesciences Corporation
86.43
-1.80%
QDEL QuidelOrtho Corporation
39.64
-0.13%
MASI Masimo Corporation
136.14
+0.67%
INSP Inspire Medical Systems, Inc.
237.45
+2.79%
BIO Bio-Rad Laboratories, Inc.
275.94
+0.12%
NARI Inari Medical, Inc.
38.42
+0.92%
BSX Boston Scientific Corporation
73.17
-0.12%
STE STERIS plc
203.90
+1.17%